|1.||Kim, Jeong-Kook: 2 articles (01/2015 - 01/2013)|
|2.||Lee, In-Kyu: 2 articles (01/2015 - 01/2013)|
|3.||Sun, Hui: 2 articles (06/2012 - 03/2008)|
|4.||Wang, Xijun: 2 articles (06/2012 - 03/2008)|
|5.||Venditti, T: 2 articles (01/2009 - 01/2006)|
|6.||D'Hallewin, G: 2 articles (01/2009 - 01/2006)|
|7.||Dore, A: 2 articles (01/2009 - 01/2006)|
|8.||Kim, Young-Jun: 2 articles (05/2006 - 02/2005)|
|9.||Jang, Seon Il: 2 articles (05/2006 - 02/2005)|
|10.||Yun, Young-Gab: 2 articles (05/2006 - 02/2005)|
|1.||Acute Lung Injury
11/01/2014 - "The purpose of this study was to investigate the protective effects and molecular mechanisms of scoparone on lipopolysaccharide (LPS)-induced acute lung injury in mice. "
11/01/2014 - "Mice model of acute lung injury (ALI), induced by intranasal instillation of LPS, was used to investigate the protective effects of scoparone in vivo. "
11/01/2014 - "Protective effects of scoparone against lipopolysaccharide-induced acute lung injury."
|2.||Acute Liver Failure (Fulminant Hepatic Failure)
07/01/2013 - "The purpose of this study was to investigate the protective effects and molecular mechanisms of scoparone on d-galactosamine (D-GalN)/lipopolysaccharide (LPS)-induced fulminant hepatic failure (FHF) in mice. "
07/01/2013 - "Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice."
12/01/2013 - "Scoparone is highly effective in treating allergic rhinitis by regulating the expression of Th1/Th2 cytokines and IgE."
12/01/2013 - "To observe changes of serum Th1/Th2 cytokines and IgE of rats with experimental allergic rhinitis (AR) treating with Scoparone (20 ml/kg, the concentration is 168 mg/L). "
12/01/2013 - "[Effect of Scoparone on Th1/Th2 cytokines and IgE in the experimental allergic rhinitis rats]."
|5.||Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
07/01/2013 - "We believe that further studies in animal model would reveal the potential therapeutic properties of 6,7-dimethoxycoumarin against anti-phospholipid syndrome. "
07/01/2013 - "Evaluation of the hypolipidemic activity of 6,7-dimethoxycoumarin on placental tissue factor mRNA expression in experimental anti-phospholipid syndrome."
07/01/2013 - "In this study, we report the lipid-lowering property and anti-tissue factor activity of one of the naturally occurring coumarin derivates 6,7-dimethoxycoumarin, found aplenty in Chinese medicinal plant Artemisia scoparia, and its effect on tissue factor mRNA expression in experimental anti-phospholipid syndrome. "
|3.||Immunoglobulin E (IgE)
|4.||Thromboplastin (Tissue Factor)
|5.||Messenger RNA (mRNA)
|9.||Interleukin-1beta (Interleukin 1 beta)
|10.||Toll-Like Receptor 4
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Chinese Traditional Medicine (Traditional Chinese Medicine)